Clarity Pharmaceuticals Ltd Stock
Stocks
CU6
AU0000165375
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.450 AUD | +2.08% |
|
+1.66% | -27.51% |
| Market Cap | 895M 626M 547M 505M 467M 879M 60.1B 6.03B 2.37B 29.43B 2.35B 2.3B 101B | P/E 2026 * |
-8.16x | P/E 2027 * | -7.5x |
|---|---|---|---|---|---|
| Enterprise Value | 734M 513M 449M 415M 383M 721M 49.3B 4.94B 1.94B 24.14B 1.93B 1.89B 83.12B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 906x |
| Free-Float |
79.07% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.08% | ||
| 1 week | +1.66% | ||
| Current month | +14.49% | ||
| 1 month | +9.38% | ||
| 3 months | -21.97% | ||
| 6 months | -27.30% | ||
| Current year | -27.51% |
| 1 week | 2.32 |  | 2.53 |
| 1 month | 1.8 | | 2.65 |
| Current year | 1.8 | | 4.26 |
| 1 year | 1.8 | | 5.87 |
| 3 years | 0.86 | | 8.98 |
| 5 years | 0.36 | | 8.98 |
| 10 years | 0.36 | | 8.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michelle Parker
CEO | Chief Executive Officer | - | 2024-10-10 |
Matthew Harris
CEO | Chief Executive Officer | - | 2009-12-31 |
David Green
DFI | Director of Finance/CFO | - | 2022-04-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Taylor
CHM | Chairman | - | 2013-10-31 |
Rosanne Robinson
BRD | Director/Board Member | - | 2010-09-30 |
Chris Roberts
BRD | Director/Board Member | 72 | 2016-03-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-21 | Sell | Chief Executive Officer | 360,896 | 0.0969% | ||
| 11-27 | Free | Chairman | 744,922 | 0.2003% | ||
| 11-27 | Free | Chief Operating Officer | 199,909 | 0.0537% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.08% | +1.66% | -24.38% | +176.84% | 626M | |
| -0.92% | -5.70% | +56.80% | +72.35% | 54.49B | |
| +6.05% | +7.79% | +62.23% | +88.46% | 55.93B | |
| +0.89% | -2.42% | +8.07% | +434.51% | 23.87B | |
| +0.37% | -4.13% | -18.56% | -16.48% | 22.86B | |
| +3.51% | +10.88% | +44.84% | -3.21% | 20B | |
| +1.76% | -0.11% | +38.87% | -29.64% | 17.48B | |
| -4.00% | -10.96% | +181.91% | +328.17% | 15.39B | |
| +7.69% | +11.91% | +50.03% | +720.96% | 15.19B | |
| -0.48% | -2.30% | +22.36% | +187.62% | 14.02B | |
| Average | +1.70% | -1.63% | +42.21% | +195.96% | 23.99B | |
| Weighted average by Cap. | +1.95% | -0.46% | +49.10% | +154.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 933K 652K 570K 527K 487K 917K 62.65M 6.28M 2.47M 30.68M 2.45M 2.4M 106M |
| Net income | -108M -75.36M -65.86M -60.88M -56.25M -106M -7.24B -726M -285M -3.54B -283M -277M -12.2B | -121M -84.49M -73.83M -68.25M -63.06M -119M -8.12B -814M -319M -3.97B -317M -310M -13.68B |
| Net Debt | -161M -112M -98.31M -90.88M -83.96M -158M -10.81B -1.08B -425M -5.29B -423M -413M -18.22B | -49.52M -34.6M -30.24M -27.95M -25.83M -48.63M -3.32B -333M -131M -1.63B -130M -127M -5.6B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-15 | A$2.450 | +2.08% | 2,681,731 |
| 26-07-14 | A$2.400 | -0.83% | 6,127,258 |
| 26-07-13 | A$2.420 | +0.41% | 1,371,003 |
| 26-07-10 | A$2.410 | +1.69% | 2,259,407 |
| 26-07-09 | A$2.370 | -1.66% | 1,962,223 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CU6 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
